IFP Advisors’s CureVac CVAC Stock Holding History

IFP Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-66	Closed	-$4K	–	4647
2022 Q3	$4K	Hold	66	–	–	﹤0.01%	4109
2022 Q2	$4K	Hold	66	–	–	﹤0.01%	3871
2022 Q1	$4K	Buy	+66	New	+$1.32K	﹤0.01%	3871

Other funds holding CVAC

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IFP Advisors's CVAC Position: Q4 2022 in Review

IFP Advisors sold out of CureVac (CVAC) in Q4 2022, closing a stake of 66 shares — an estimated $4K sold.

IFP Advisors first reported a position in CVAC in Q1 2022 and held it in 3 quarters. The position peaked at $4K in Q3 2022. 83 funds tracked by Wall St. Rank hold CVAC as of Q4 2022.

IFP Advisors reported no remaining CureVac position as of Q4 2022 after selling out during the quarter.
IFP Advisors sold 66 CureVac shares in Q4 2022, an estimated $4K.
IFP Advisors first reported a position in CureVac in Q1 2022 and held it in 3 quarters.
IFP Advisors's CureVac position peaked at $4K in Q3 2022.
83 funds tracked by Wall St. Rank held CureVac as of Q4 2022.

Based on IFP Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.